COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Qualitative Study Into How Patients Deal With Chemotherapy-related Side Effects at Home

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01867489
Recruitment Status : Completed
First Posted : June 4, 2013
Last Update Posted : November 18, 2014
Information provided by (Responsible Party):
Annemarie Coolbrandt, Universitaire Ziekenhuizen Leuven

Brief Summary:
This qualitative study explores how patients deal with the side effects from chemotherapy at their home, what factors and ideas influence their symptom self-management and how professional caregivers contribute to the management of their symptoms at home. Data are collected through semi-structured interviews with adult patients treated with chemotherapy and analysed using a Grounded Theory approach.

Condition or disease Intervention/treatment
Exploration of How Patients Deal With Side Effects From Chemotherapy Other: No intervention

Layout table for study information
Study Type : Observational
Actual Enrollment : 28 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: A Qualitative Study Into How Patients With Cancer Deal With Chemotherapy-Related Side Effects at Home
Study Start Date : September 2012
Actual Primary Completion Date : January 2014
Actual Study Completion Date : January 2014

Group/Cohort Intervention/treatment
Chemotherapy, Cancer
Adult cancer patients (with any type of cancer) being treated with chemotherapy
Other: No intervention

Primary Outcome Measures :
  1. patient's experience [ Time Frame: one interview during the course of treatment, i.e. one timepoint between 2 months after the start of chemotherapy and the end of the patient's treatment ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Adult patients treated with chemotherapy

Inclusion Criteria:

  • Adult (≥18 years) patients with (any type and any stage of) cancer who were undergoing chemotherapy treatment in an ambulatory setting or during short hospital stays
  • Dutch speaking
  • Able to provide informed consent and to participate in an interview

Exclusion Criteria:

  • Patients who were in the first 2 cycles of treatment
  • Patients for whom an interview was considered physically, mentally and/or emotionally too burdensome.
  • Patients who had reported not to experience any side effect from treatment at all

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01867489

Layout table for location information
UZ Leuven
Leuven, Belgium
Sponsors and Collaborators
Universitaire Ziekenhuizen Leuven
Layout table for additonal information
Responsible Party: Annemarie Coolbrandt, Clinical Nurse Specialist Oncology, Universitaire Ziekenhuizen Leuven Identifier: NCT01867489    
Other Study ID Numbers: B322201214929
First Posted: June 4, 2013    Key Record Dates
Last Update Posted: November 18, 2014
Last Verified: November 2014